Viewing Study NCT03517969


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2025-12-25 @ 8:40 PM
Study NCT ID: NCT03517969
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-20
First Post: 2018-05-07
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: M6620 and Carboplatin With or Without Docetaxel in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-05-29
Start Date Type: ACTUAL
Primary Completion Date: 2021-08-10
Primary Completion Date Type: ACTUAL
Completion Date: 2026-04-03
Completion Date Type: ESTIMATED
First Submit Date: 2018-05-07
First Submit QC Date: None
Study First Post Date: 2018-05-08
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-04-23
Results First Submit QC Date: None
Results First Post Date: 2025-05-08
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-10-04
Last Update Post Date: 2025-10-20
Last Update Post Date Type: ESTIMATED